HER2-positive Breast Cancer Clinical Trials
3 recruiting trials for HER2-positive Breast Cancer. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT06328465
fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases
The aim of this study is to understand whether DWB-MRI (Diffusion Whole Body-Magnetic Resonance Imaging) is useful for early detection of locoregional or distant recurrence and...
Sponsor: European Institute of OncologyEnrolling: 1451 location
RECRUITINGPhase 2NCT05834764
Pyrotinib in Women With High-risk in Early Stage Breast Cancer
ExteNET study explored neratinib prolong anti-HER2 therapy after trastuzumab therapy found that it can improve disease-free survival in patients with lymph nodes positive; In...
Sponsor: The First Affiliated Hospital with Nanjing Medical UniversityEnrolling: 1881 location
RECRUITINGPhase 1NCT06253871
A Phase 1/1b Study of IAM1363 in HER2 Cancers
This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 in participants with...
Sponsor: Iambic Therapeutics, IncEnrolling: 24320 locations